Skip to content
THE VELRI LIBRARY

Understand your health. Know what to ask.

Guides to treatments, lab results and common health questions. Sources are listed in every article.

All guides

201 guides · Page 2 of 17
Longevity & PerformanceLongevity

What medical oversight adds to a peptide decision

Tracking symptoms and lab numbers cannot establish whether a peptide is appropriate. What a provider and pharmacy each need to clarify.

3 sources · FDARead · 2 min →
Longevity & PerformanceLongevity

Fatigue after weeks of overtime: what else could contribute?

Long hours can disrupt sleep, but persistent fatigue also deserves a symptom and medication review. Testing should follow the question being investigated.

4 sources · Endocrine SocietyRead · 2 min →
Trust & Safety

What a peptide purity report leaves unanswered

A purity percentage is one detail about a sample. What still needs to be established about an online vial, its source and its intended use.

3 sources · FDARead · 2 min →
Hormones & Vitality

Strength and protein after menopause: what to assess

Changes in strength deserve a look at activity, nutrition, symptoms, and health. A protein product or hormone result cannot explain the whole picture.

4 sources · PubMed / PMCRead · 2 min →
Biomarkers & Labs

Feeling well: what a baseline health visit can still tell you

Blood pressure and selected blood tests can add information you cannot get from how strong or energetic you feel.

Read · 2 min →
Longevity & PerformanceLongevity

Lean mass and grip strength are different measurements

A body scan estimates tissue; a grip test measures force. Why muscle quantity and physical strength do not always change together.

2 sources · PubMed / PMCRead · 2 min →
Weight & Metabolic

Perimenopause and GLP-1 medicines: clarify the weight and glucose questions

How changing body composition, glucose results and medication eligibility fit together during perimenopause.

4 sources · PubMed / PMC, NIH, The Menopause SocietyRead · 2 min →
Longevity & PerformanceLongevity

A first NAD+ consultation: evidence and expectations

For frequent travelers considering NAD+, the important questions are what is causing fatigue, which product is proposed and what evidence supports it.

4 sources · FDA, PubMed / PMCRead · 2 min →
Weight & Metabolic

How tirzepatide works: GIP and GLP-1, explained

Tirzepatide acts on two hormone receptors involved in appetite and glucose regulation. Here is what that means in plain English.

2 sources · FDA, NIHRead · 2 min →
Weight & Metabolic

Who can be considered for weight-management medication?

BMI is one part of eligibility. Weight-related conditions, medical history, medicines and the specific product also shape the decision.

2 sources · NIHRead · 2 min →
Longevity & PerformanceLongevity

Persistent fatigue: what to check before considering NAD+

Fatigue can have several causes. Learn how sleep, symptoms and selected blood tests shape an evaluation before NAD+ enters the conversation.

4 sources · PubMed / PMC, NIHRead · 2 min →
Weight & Metabolic

Who is responsible for a compounded tirzepatide prescription?

The prescriber, dispensing pharmacy and online service have different roles. What to identify before starting a prescription order.

3 sources · FDARead · 2 min →